Jason Hafron

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Myovant Sciences Inc.
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Myovant Sciences Inc.
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Nucleix
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Pfizer Inc.
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Pfizer Inc.
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Procept-Biorobotic
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Progenics Pharmaceuticals, Inc.
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Tolmar Pharmaceuticals Inc.
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Urogen Pharma Inc.
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Promaxo
    Date added:
    09/20/2023
    Date updated:
    09/20/2023

Pages

Return to 2023 Midwest Precision Oncology Symposium